Sagimet Biosciences (SGMT) Free Cash Flow: 2022-2024
Historic Free Cash Flow for Sagimet Biosciences (SGMT) over the last 3 years, with Dec 2024 value amounting to -$42.4 million.
- Sagimet Biosciences' Free Cash Flow fell 404.49% to -$19.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$38.5 million, marking a year-over-year change of. This contributed to the annual value of -$42.4 million for FY2024, which is 78.55% down from last year.
- Latest data reveals that Sagimet Biosciences reported Free Cash Flow of -$42.4 million as of FY2024, which was down 78.55% from -$23.8 million recorded in FY2023.
- In the past 5 years, Sagimet Biosciences' Free Cash Flow ranged from a high of -$23.8 million in FY2023 and a low of -$42.4 million during FY2024.
- For the 3-year period, Sagimet Biosciences' Free Cash Flow averaged around -$30.2 million, with its median value being -$24.5 million (2022).
- Per our database at Business Quant, Sagimet Biosciences' Free Cash Flow increased by 2.96% in 2023 and then plummeted by 78.55% in 2024.
- Yearly analysis of 3 years shows Sagimet Biosciences' Free Cash Flow stood at -$24.5 million in 2022, then increased by 2.96% to -$23.8 million in 2023, then plummeted by 78.55% to -$42.4 million in 2024.